- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07408310
Trial of Spiritual Care Interventions for Patients With Cancer
June 1, 2026 updated by: Weill Medical College of Cornell University
This study aims to determine the effects of 2 spiritual care interventions.
Spiritual wellness and healthcare service utilization will be measured from a sample of advanced cancer patients recruited from outpatient settings.
Study Overview
Status
Recruiting
Conditions
Detailed Description
This study is a stratified permuted-block RCT to determine the effects of 2 spiritual care interventions on advanced cancer patients' spiritual wellness (i.e., spiritual well-being and satisfaction of spiritual care needs) and specific forms of healthcare service utilization (i.e., hospice enrollment and ICU admissions) in a sample of advanced cancer patients (N=288) recruited from outpatient settings.
Patients will be assigned to "Spiritual Care Intervention #1" (active 1), "Spiritual Care Intervention #2" (active 2), or "Spiritual Care Intervention #3" (control) arm of the trial (overall ratio 1:1:1) using permuted-block randomization within strata defined by geographic location (NYC, Houston Metro Area) and recruitment site (NYC: BMH; Houston Metro Area: UTMB, MDACC).
Spiritual care intervention details are being withheld until the trial concludes to protect the scientific integrity of the study.
Only 1 of the 2 active interventions will be administered at each site at a given time to avoid within-site cross-contamination between the 2 active intervention arms of the trial.
Study Type
Interventional
Enrollment (Estimated)
288
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Madison K Pavao, B.S.
- Phone Number: (646)962-5650
- Email: mkp4005@med.cornell.edu
Study Contact Backup
- Name: Paul K Maciejewski, Ph.D.
- Phone Number: 646-962-7169
- Email: pam2056@med.cornell.edu
Study Locations
-
-
New York
-
New York, New York, United States, 11215
- Recruiting
- New York Presbyterian Brooklyn Methodist Hospital
-
Contact:
- Alan B Astrow, M.D.
- Phone Number: (718) 780-5824
- Email: ala9124@med.cornell.edu
-
Principal Investigator:
- Alan B Astrow, M.D.
-
-
Texas
-
Galveston, Texas, United States, 77555
- Recruiting
- The University of Texas Medical Branch, Galveston
-
Contact:
- Mukaila Raji, M.D.
- Phone Number: (409) 772-1989
- Email: muraji@UTMB.EDU
-
Principal Investigator:
- Mukaila Raji, M.D.
-
Houston, Texas, United States, 77030
- Recruiting
- M.D. Anderson Cancer Center
-
Contact:
- David Hui, M.D.
- Phone Number: (713) 563-7630
- Email: DHui@mdanderson.org
-
Principal Investigator:
- David Hui, M.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
- Diagnosed with an advanced cancer.
- Member of a religious faith community organization.
- Fluent in English.
Exclusion Criteria:
- Received spiritual care from a healthcare chaplain within the past 2 months.
- Too weak or cognitively impaired to engage in study activities.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Spiritual Care Intervention #1
This is an experimental condition arm.
Intervention details are being withheld until the trial concludes to protect the scientific integrity of the study.
|
Experimental
|
|
Experimental: Spiritual Care Intervention #2
This is also an experimental condition arm.
Intervention details are being withheld until the trial concludes to protect the scientific integrity of the study.
|
Experimental
|
|
Active Comparator: Spiritual Care Intervention #3
This is the active comparator condition arm.
Intervention details are being withheld until the trial concludes to protect the scientific integrity of the study.
|
Active Comparator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' spiritual wellness as assessed by measures of spiritual well-being
Time Frame: 2 months
|
The spiritual well-being outcome measure for this trial is the total score for the 12-item Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being Scale [FACIT-Sp-12], which has a range from 0 to 48.
The higher the score, the greater the spiritual well-being.
|
2 months
|
|
Participants' number of hospice enrollments
Time Frame: up to 12 months
|
Number of hospice enrollments over time, up to 12 months.
|
up to 12 months
|
|
Participants' number of ICU admissions
Time Frame: up to 12 months
|
Number of ICU admissions over time, up to 12 months.
|
up to 12 months
|
|
Patients' spiritual wellness as assessed by measures of satisfaction of spiritual care needs.
Time Frame: 2 months
|
The satisfaction of spiritual care needs outcome measure for this trial is a reverse-coded total score for the 13-item Spiritual Needs Assessment for Patients [SNAP], which measures unmet spiritual care needs and has a range from 13 to 52.
The higher the reverse-coded score, the greater the satisfaction of spiritual care needs.
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' quality of life
Time Frame: 2 months
|
The quality-of-life outcome measure for this trial is the total score for the 27-item Functional Assessment of Cancer Therapy - General [FACT-G], which has a range of 0 to 108.
The higher the score, the greater the quality of life.
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Paul K Maciejewski, Ph.D., Weill Medical College of Cornell University
- Principal Investigator: Alan B Astrow, M.D., NYP Brooklyn Methodist Hospital
- Principal Investigator: Mukaila Raji, M.D., The University of Texas Medical Branch
- Principal Investigator: David Hui, M.D., M.D. Anderson Cancer Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 24, 2026
Primary Completion (Estimated)
April 1, 2029
Study Completion (Estimated)
June 1, 2029
Study Registration Dates
First Submitted
January 29, 2026
First Submitted That Met QC Criteria
February 9, 2026
First Posted (Actual)
February 13, 2026
Study Record Updates
Last Update Posted (Actual)
June 2, 2026
Last Update Submitted That Met QC Criteria
June 1, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 24-08027855
- R01NR021159 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Advanced Cancer
-
UNICANCERRecruitingAdvanced Breast Cancer | Advanced Gastric Cancer | Advanced Urothelial Cancer | Advanced Non Small Cell Lung Cancer (NSCLC)France
-
Icahn School of Medicine at Mount SinaiNational Institute of Nursing Research (NINR)Not yet recruitingAdvanced Heart Failure | Advanced Lung Cancer | Advanced Triple Negative Breast Cancer | Advanced Non-Colorectal Gastrointestinal CancerUnited States
-
Teon Therapeutics, Inc.Merck Sharp & Dohme LLCTerminatedCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
Zhejiang UniversityRecruitingAdvanced Colorectal Cancer | Advanced Hepatocellular Carcinoma | Advanced Gastric Cancer | Advanced Pancreatic CancerChina
-
STORM Therapeutics LTDCompletedCancer | Advanced Solid Tumor | Advanced CancerUnited States
-
Merck Sharp & Dohme LLCCompletedAdvanced Cancer Relapsed | Advanced Cancer Refractory
-
BiOneCure Therapeutics Inc.RecruitingCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
PfizerRecruitingAdvanced Cancer | Advanced MalignanciesUnited States
-
Shanghai Allink Biotherapeutics Co., Ltd.RecruitingAdvanced Solid Tumor | Advanced CancerAustralia, United States
-
Chinese PLA General HospitalNot yet recruitingTreatment for Advanced Colorectal Cancer | Treatment for Advanced Pancreatic Cancer
Clinical Trials on Spiritual Care Intervention #1
-
Weill Medical College of Cornell UniversityNational Institute on Minority Health and Health Disparities (NIMHD); The University... and other collaboratorsRecruiting
-
Indiana UniversityIndiana University HealthCompletedFeasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and InterventionMetastatic Cancer | Advanced CancerUnited States
-
Indiana UniversityIndiana University Health; Regenstrief Institute, Inc.CompletedDepression | PTSD | Anxiety | Communication | SatisfactionUnited States
-
Recep Tayyip Erdogan UniversityCompletedSpiritual CareTurkey (Türkiye)
-
Indiana UniversityNational Institutes of Health (NIH); National Institute on Aging (NIA); University... and other collaboratorsNot yet recruiting
-
The Methodist Hospital Research InstituteRecruiting
-
Universitas Noor Huda MustofaCompletedType 2 Diabetes Mellitus (T2DM)Indonesia
-
Indiana UniversityWalther Cancer FoundationRecruitingStage IV Lung Cancer | Stage IV Gastrointestinal CancerUnited States
-
Port Said UniversityNot yet recruitingWell-being | CompetenceEgypt
-
Wake Forest University Health SciencesWithdrawnCancer | Young Adult CancerUnited States